A Chlorin e6 derivative-mediated photodynamic therapy versus doxycycline for moderate-to-severe rosacea: A prospective, randomized, controlled study

Background: Photodynamic therapy (PDT) is beneficial for managing rosacea, and chlorin e6 derivative-mediated photodynamic therapy (STBF-PDT) has demonstrated efficacy in reducing acne lesions with mild adverse reactions. Objectives: This study aimed to assess the effectiveness and safety of STBF-PD...

Full description

Saved in:
Bibliographic Details
Main Authors: Yun Wu, Qing Fan, Xiaojing Liu, Yajing Cao, Jin Yang, Yu Yan, Hui Tao, Fuhe Zhang, Linglin Zhang, Peiru Wang, Xiuli Wang
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Photodiagnosis and Photodynamic Therapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1572100025000043
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832575465998516224
author Yun Wu
Qing Fan
Xiaojing Liu
Yajing Cao
Jin Yang
Yu Yan
Hui Tao
Fuhe Zhang
Linglin Zhang
Peiru Wang
Xiuli Wang
author_facet Yun Wu
Qing Fan
Xiaojing Liu
Yajing Cao
Jin Yang
Yu Yan
Hui Tao
Fuhe Zhang
Linglin Zhang
Peiru Wang
Xiuli Wang
author_sort Yun Wu
collection DOAJ
description Background: Photodynamic therapy (PDT) is beneficial for managing rosacea, and chlorin e6 derivative-mediated photodynamic therapy (STBF-PDT) has demonstrated efficacy in reducing acne lesions with mild adverse reactions. Objectives: This study aimed to assess the effectiveness and safety of STBF-PDT for the treatment of moderate-to-severe rosacea. Methods: In this prospective, randomised, evaluator-blind controlled study, patients with moderate-to-severe rosacea were assigned to receive up to six STBF-PDT sessions or 100 mg of doxycycline daily for eight weeks, followed by a 24-week follow-up. Results: A total of 76 patients were enrolled (38 assigned to STBF-PDT and 38 to oral doxycycline) with 69 (36 in the STBF-PDT group and 33 in the doxycycline group) completing the study. At the end of treatment, the median reduction in lesion count was 82.3 % in the STBF-PDT group and 81.8 % in the doxycycline group, indicating no significant difference between the groups. The STBF-PDT group exhibited a lower relapse rate and a significantly higher reduction in Demodex mites. Clinician's Erythema Assessment success (CEA), sensations of burning and pruritus, telangiectasia, and Rosacea-related Quality of Life (RosaQoL) scores were comparable between groups. No severe adverse reactions were observed. Conclusions: STBF-PDT is a promising treatment option for mild-to-moderate rosacea with mild adverse reactions.
format Article
id doaj-art-917a679e9b604c599c32f4367603dd82
institution Kabale University
issn 1572-1000
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Photodiagnosis and Photodynamic Therapy
spelling doaj-art-917a679e9b604c599c32f4367603dd822025-02-01T04:11:50ZengElsevierPhotodiagnosis and Photodynamic Therapy1572-10002025-02-0151104474A Chlorin e6 derivative-mediated photodynamic therapy versus doxycycline for moderate-to-severe rosacea: A prospective, randomized, controlled studyYun Wu0Qing Fan1Xiaojing Liu2Yajing Cao3Jin Yang4Yu Yan5Hui Tao6Fuhe Zhang7Linglin Zhang8Peiru Wang9Xiuli Wang10Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, ChinaDepartment of Dermatology, Shanghai Fengxian District Central Hospital, Shanghai, 201499, ChinaInstitute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, ChinaInstitute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, ChinaInstitute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, ChinaInstitute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, ChinaInstitute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, ChinaDepartment of Dermatology, Shanghai Fengxian District Central Hospital, Shanghai, 201499, ChinaInstitute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China; Corresponding authors.Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China; Corresponding authors.Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, 200443, China; Corresponding authors.Background: Photodynamic therapy (PDT) is beneficial for managing rosacea, and chlorin e6 derivative-mediated photodynamic therapy (STBF-PDT) has demonstrated efficacy in reducing acne lesions with mild adverse reactions. Objectives: This study aimed to assess the effectiveness and safety of STBF-PDT for the treatment of moderate-to-severe rosacea. Methods: In this prospective, randomised, evaluator-blind controlled study, patients with moderate-to-severe rosacea were assigned to receive up to six STBF-PDT sessions or 100 mg of doxycycline daily for eight weeks, followed by a 24-week follow-up. Results: A total of 76 patients were enrolled (38 assigned to STBF-PDT and 38 to oral doxycycline) with 69 (36 in the STBF-PDT group and 33 in the doxycycline group) completing the study. At the end of treatment, the median reduction in lesion count was 82.3 % in the STBF-PDT group and 81.8 % in the doxycycline group, indicating no significant difference between the groups. The STBF-PDT group exhibited a lower relapse rate and a significantly higher reduction in Demodex mites. Clinician's Erythema Assessment success (CEA), sensations of burning and pruritus, telangiectasia, and Rosacea-related Quality of Life (RosaQoL) scores were comparable between groups. No severe adverse reactions were observed. Conclusions: STBF-PDT is a promising treatment option for mild-to-moderate rosacea with mild adverse reactions.http://www.sciencedirect.com/science/article/pii/S1572100025000043Photodynamic therapyRosaceaErythemaPapulopustularDoxycycline
spellingShingle Yun Wu
Qing Fan
Xiaojing Liu
Yajing Cao
Jin Yang
Yu Yan
Hui Tao
Fuhe Zhang
Linglin Zhang
Peiru Wang
Xiuli Wang
A Chlorin e6 derivative-mediated photodynamic therapy versus doxycycline for moderate-to-severe rosacea: A prospective, randomized, controlled study
Photodiagnosis and Photodynamic Therapy
Photodynamic therapy
Rosacea
Erythema
Papulopustular
Doxycycline
title A Chlorin e6 derivative-mediated photodynamic therapy versus doxycycline for moderate-to-severe rosacea: A prospective, randomized, controlled study
title_full A Chlorin e6 derivative-mediated photodynamic therapy versus doxycycline for moderate-to-severe rosacea: A prospective, randomized, controlled study
title_fullStr A Chlorin e6 derivative-mediated photodynamic therapy versus doxycycline for moderate-to-severe rosacea: A prospective, randomized, controlled study
title_full_unstemmed A Chlorin e6 derivative-mediated photodynamic therapy versus doxycycline for moderate-to-severe rosacea: A prospective, randomized, controlled study
title_short A Chlorin e6 derivative-mediated photodynamic therapy versus doxycycline for moderate-to-severe rosacea: A prospective, randomized, controlled study
title_sort chlorin e6 derivative mediated photodynamic therapy versus doxycycline for moderate to severe rosacea a prospective randomized controlled study
topic Photodynamic therapy
Rosacea
Erythema
Papulopustular
Doxycycline
url http://www.sciencedirect.com/science/article/pii/S1572100025000043
work_keys_str_mv AT yunwu achlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT qingfan achlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT xiaojingliu achlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT yajingcao achlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT jinyang achlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT yuyan achlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT huitao achlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT fuhezhang achlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT linglinzhang achlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT peiruwang achlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT xiuliwang achlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT yunwu chlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT qingfan chlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT xiaojingliu chlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT yajingcao chlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT jinyang chlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT yuyan chlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT huitao chlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT fuhezhang chlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT linglinzhang chlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT peiruwang chlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy
AT xiuliwang chlorine6derivativemediatedphotodynamictherapyversusdoxycyclineformoderatetosevererosaceaaprospectiverandomizedcontrolledstudy